Which of the following is not a potential trial endpoint?
The potential endpoint are:
- Dosage of study drug.
- Time to disease relapse
- Biochemical marker of disease
- Patient’s stress level
- Cost of patient’s care over a given time period
Dosage of study drug.
[Correct! Dosage of study drug does not reflect efficacy or safety aspect of study drug and therefore cannot be used as an endpoint.]
Time to disease relapse
[Incorrect! Time to disease relapse is often used as an endpoint to indicate timing and occurance of disease relapse.]
Biochemical marker of disease
[Incorrect! Biochemical marker of disease is often used as a surrogate endpoint in clinical trials.]
Patient’s stress level
[Incorrect! Patient’s stress level is often used as an endpoint in stress management interventional studies.]
Cost of patient’s care over a given time period
[Incorrect! Cost of patient’s care over a given time period is often used in clinical trials to measure health economics of study drug.]